Inorganic Polyphosphate Amplifies High Mobility Group Box 1–Mediated Von Willebrand Factor Release and Platelet String Formation on Endothelial Cells. Issue 8 (August 2018)

• Record Type: Journal Article
• Authors: Biswas, Indranil; Panicker, Sumith R.; Cai, Xiaofeng; Mehta-D'souza, Padmaja; Rezaie, Alireza R.
• Is Part Of: Arteriosclerosis, thrombosis, and vascular biology. Volume 38:Issue 8(2018)
• Publication Date: 2018-08
• Subjects: advanced glycation end products -- angiopoietin-2 -- blood platelets -- endothelial cells -- von Willebrand factor; Arteriosclerosis -- Periodicals; Thrombosis -- Periodicals; Blood-vessels -- Pathophysiology -- Periodicals; Electronic journals; 616.13
• DOI: 10.1161/ATVBAHA.118.311165
• Languages: English
• ISSNs: 1079-5642

Abstract

Abstract : Objective—: Inorganic polyphosphate (polyP) is known to modulate coagulation, inflammation, and metabolic pathways. It also amplifies inflammatory responses of HMGB1 (high mobility group box 1) in endothelial cells. The objective of this study was to evaluate the effect of polyP on von Willebrand factor (VWF) release from endothelial cells with or without HMGB1. Approach and Results—: EA.hy926 endothelial cells were treated with different concentrations of polyP70 alone or in combination with different concentrations of HMGB1. VWF release was measured by an ELISA assay in the absence or presence of pharmacological inhibitors of the receptor for advanced glycation end products, P2Y1, and Ca 2+ . A flow chamber assay was used to monitor polyP70 -mediated platelet recruitment and VWF-platelet string formation. PolyP70 and HMGB1 induced VWF release from endothelial cells by a concentration-dependent manner. PolyP70 amplified HMGB1-mediated VWF release from endothelial cells. This was also true if boiled platelet releasate was used as the source of polyP. Gene silencing or pharmacological inhibitors of receptor for advanced glycation end products, P2Y1, and Ca 2+ significantly inhibited VWF release. PolyP70 and HMGB1 synergistically promoted VWF-platelet string formation in the flow chamber assay, which was inhibited by the anti-GPIbα (glycoprotein Ib alpha) antibody. VWF release by polyP70 -HMGB1 complex required phosphorylation of Src and phospholipase C because inhibitors of Src, phospholipase C, and Ca 2+ signaling significantly decreased VWF secretion. The polyP70 -HMGB1 complex also increased angiopoietin-2 release, indicating that Weibel-Palade body exocytosis is involved in the VWF release. Conclusions—: PolyP70 can promote thrombotic and inflammatory pathways by inducing VWF release and platelet string formation on endothelial cells. Abstract : Supplemental Digital Content is available in the text.